Globus Medical Inc

GMED

Add to Watchlist

76.140USD

+0.010+0.01%

Market hours （ET）Quotes delayed by 15 min

Globus Medical Inc's Score

Industry at a Glance

Industry Ranking

44 / 206

Overall Ranking

135 / 4490

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Globus Medical Inc Highlights

StrengthsRisks

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 87.37% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.94B.

Undervalued

The company’s latest PE is 17.52, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 115.75M shares, decreasing 13.06% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 1.11K shares of this stock.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

108.286

Target Price

+38.92%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Globus Medical Inc is 8.93, ranking 11 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 759.85M, representing a year-over-year increase of 27.04%, while its net profit experienced a year-over-year increase of 64.72%.

Score

Industry at a Glance

Previous score

8.93

Change

0



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.76

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.06

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.29

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.55

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Globus Medical Inc is 7.35, ranking 92 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 17.52, which is 1970.10% below the recent high of 362.76 and 0.00% above the recent low of 17.52.

Score

Industry at a Glance

Previous score

7.35

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 44/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Globus Medical Inc is 7.63, ranking 126 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 92.00, with a high of 114.00 and a low of 76.00.

Score

Industry at a Glance

Previous score

7.63

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Globus Medical Inc is 6.69, ranking 109 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 90.49 and the support level at 68.66, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.58

Change

0.11

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-12

The current institutional shareholding score of Globus Medical Inc is 7.00, ranking 80 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 85.62%, representing a quarter-over-quarter decrease of 19.82%. The largest institutional shareholder is Invesco, holding a total of 860.21K shares, representing 0.76% of shares outstanding, with 10.62% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

9.40M

-2.87%

Janus Henderson Investors

7.29M

-3.41%

State Street Investment Management (US)

3.46M

+0.06%

Burgundy Asset Management Ltd.

3.35M

-3.20%

Invesco Advisers, Inc.

3.03M

+2206.59%

Sculptor Capital Management, Inc

3.00M

-14.29%

JP Morgan Asset Management

2.96M

-13.80%

Madison Avenue Partners LP

2.62M

+3.01%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Globus Medical Inc is 5.73, ranking 73 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.00. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Globus Medical Inc’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.

Globus Medical Inc

GMED

7.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.76 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.57 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.30 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment